FDA Regulatory Writing & Strategy for a Global Pharmaceutical Company

Context

A global pharmaceutical corporation required regulatory documentation for a complex drug-related pathway, with high expectations for clarity and traceability.

Overview

Assisted the client’s regulatory affairs organisation in preparing documentation and plans tailored to applicable FDA documentation expectations for the engagement.

Approach

1. Map procedure context and documentation needs with RA stakeholders
2. Author and structure the regulatory plan end-to-end for the client’s use
3. Documentation support considered applicable electronic records and electronic signature requirements under 21 CFR Part 11 where relevant to the engagement scope
4. Iterate with the client’s regulatory affairs team through to a package the client could submit

What we did

• Prepared the regulatory plan from initial framing through a complete, structured package for the client
• Collaborated on clarity and traceability across source materials
• Documentation and strategy support; the client remained the party of record

What mattered

• End-to-end ownership of the plan structure — not fragmented drafting without a single narrative
• Traceability between source evidence and regulatory language under the client’s RA process
• We supported documentation practices addressing applicable 21 CFR Part 11 requirements where the engagement involved controlled electronic records
• Clear separation: we support writing and strategy; the client owns the submission

Result

We prepared the plan from start to finish. The client submitted it to the U.S. Food and Drug Administration (FDA), and the plan was formally approved by the FDA. The client remained the party of record. This approval related specifically to the plan and was distinct from any separate FDA clearance, approval or authorization of a marketed product.

Notes

• The client owned the submission and agency interactions
• The stated outcome is for this engagement’s plan
• Published only in anonymised form

Related

Regulatory support · Biotech & Pharma · How we work